Vasopressin

Product NDC: 63323-302
11-digit product format: 633230302
Labeler code: 63323
Product ID: 63323-302_9af1ae6c-e1ef-28ff-e053-2a95a90ac717
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: VASOPRESSIN
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR; SUBCUTANEOUS
Labeler: Fresenius Kabi USA, LLC
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 2001-07-17
Marketing end: 0000-00-00
Substance: VASOPRESSIN
Active strength: 20 [USP'U]/mL
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63323-302		D	Discontinued by firm	2026-08-11
excluded product	product	63323-302		D	Discontinued by firm	2026-08-11
excluded package	package	63323-302	63323-302-09	D	Discontinued by firm	2026-08-11
excluded package	package	63323-302	63323-302-01	D	Discontinued by firm	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63323-302-09	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63323-302-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63323-302-09	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63323-302-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63323-302-09	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63323-302-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63323-302-09	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63323-302-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63323-302-09	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63323-302-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63323-302-09	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63323-302-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63323-302-09	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63323-302-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63323-302-09	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63323-302-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63323-302-09	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63323-302-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63323-302-09	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63323-302-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63323-302-09	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63323-302-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63323-302-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63323-302-01	`557ba5c1ecfa…`	`9c80585c8c6e…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
99568ea8-9af8-47ab-8eb5-5730f9428dbd	Product name	1	20250625
0f6574b6-8c6c-4325-9a2b-e8f85e32ee4e	Product name	1	20250305
704c08d7-cc3f-4fb2-a29e-57130a255781	Product name	4	20241218
6ac8356f-c51e-45ae-a595-aa1fad5b69a2	Product name	1	20210223
48747306-602a-42cc-957b-5b0c69158eee	Product name	1	20180604
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63323-302-01	ML - Milliliter	63323-302	0bd962b8-76a9-4123-83a7-c6bb8cf4d728	1	2013-02-13
63323-302-09	ML - Milliliter	63323-302	de278d0a-71fe-4623-9eaa-0b9aef5c5e82	1	2014-08-01

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
VASOPRESSIN	ACTIVE INGREDIENT	Y87Y826H08	VASOPRESSIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2
VASOPRESSIN	ACTIVE MOIETY	Y87Y826H08	VASOPRESSIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2
ACETIC ACID	INACTIVE INGREDIENT	Q40Q9N063P	VASOPRESSIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2
CHLOROBUTANOL	INACTIVE INGREDIENT	HM4YQM8WRC	VASOPRESSIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	VASOPRESSIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2
VASOPRESSIN	ACTIVE INGREDIENT	Y87Y826H08	VASOPRESSIN INJECTION, SOLUTION [FENERAL INJECTABLES & VACCINES, INC]	1
VASOPRESSIN	ACTIVE MOIETY	Y87Y826H08	VASOPRESSIN INJECTION, SOLUTION [FENERAL INJECTABLES & VACCINES, INC]	1
ACETIC ACID	INACTIVE INGREDIENT	Q40Q9N063P	VASOPRESSIN INJECTION, SOLUTION [FENERAL INJECTABLES & VACCINES, INC]	1
CHLOROBUTANOL	INACTIVE INGREDIENT	HM4YQM8WRC	VASOPRESSIN INJECTION, SOLUTION [FENERAL INJECTABLES & VACCINES, INC]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	VASOPRESSIN INJECTION, SOLUTION [FENERAL INJECTABLES & VACCINES, INC]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
Y4907O6MFD	VASOPRESSIN	113-79-1	VASOPRESSIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313578	vasopressin 20 UNT/ML Injectable Solution	PSN	40dab227-b05b-4e72-a59c-6e6f8a80252e	3
313578	vasopressin (USP) 20 UNT/ML Injectable Solution	SCD	40dab227-b05b-4e72-a59c-6e6f8a80252e	3

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Vasopressin Injection, USP	Fresenius Kabi USA, LLC	2019-12-30	HUMAN PRESCRIPTION DRUG LABEL	4
VASOPRESSIN INJECTION, USP (SYNTHETIC)	Feneral Injectables & Vaccines, Inc	2017-01-23	HUMAN PRESCRIPTION DRUG LABEL	3